Clinical trial
Community - Associated Extended-spectrum Beta-lactamases (ESBL)
NCT00363220 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00363220 |
|---|---|
| Title | Community - Associated Extended-spectrum Beta-lactamases (ESBL) |
| Official title | Community - Associated Extended-spectrum Beta-lactamases (ESBL) |
| Lead sponsor | University of Pittsburgh, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Infection, E Coli Infections, Klebsiella Infections, Proteus Infections |
| Enrollment | 100 |
| Start date | Aug 1, 2006 |
| Primary completion | Dec 1, 2015 |
| Completion | Dec 1, 2015 |
| First posted | Aug 15, 2006 |
| Last update posted | Dec 17, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: